Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031

This study has been terminated.
(change development strategy)
Sponsor:
Information provided by (Responsible Party):
Daewoong Pharmaceutical Co. LTD.
ClinicalTrials.gov Identifier:
NCT01522586
First received: January 27, 2012
Last updated: February 12, 2014
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2013
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)